Medexus Pharmaceuticals Inc
TSX:MDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
I
|
Ionic Rare Earths Ltd
OTC:IXRRF
|
AU |
|
Antero Resources Corp
NYSE:AR
|
US |
|
Lakes Blue Energy NL
ASX:LKO
|
AU |
|
Polymetal International PLC
LSE:POLY
|
CY |
|
Enjin Co Ltd
TSE:7370
|
JP |
|
Precious Dragon Technology Holdings Ltd
HKEX:1861
|
CN |
|
Taiwan Semiconductor Manufacturing Co Ltd
NYSE:TSM
|
TW |
|
S
|
Sealsq Corp
NASDAQ:LAES
|
CH |
|
P
|
Pharol SGPS SA
ELI:PHR
|
PT |
|
I
|
International Consolidated Airlines Group SA
MAD:IAG
|
UK |
|
EML Payments Ltd
ASX:EML
|
AU |
|
Inspired Entertainment Inc
F:4U8
|
US |
|
Entech SA
PAR:ALESE
|
FR |
|
Super Retail Group Ltd
ASX:SUL
|
AU |
|
Meteoric Resources NL
ASX:MEI
|
AU |
|
S
|
Samyang Foods Co Ltd
KRX:003230
|
KR |
Bankruptcy Probability
Medexus Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Medexus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
129.6m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
567.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
284.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
204.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
334.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Medexus Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Medexus Pharmaceuticals Inc has total debt of 18.2m USD. This includes both short-term (0 USD) and long-term (18.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
